ImmunityBio Inc. (IBRX) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ImmunityBio Inc. (IBRX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.46

0.14 (6.03%)

At close: Jan 15, 2025, 10:03 AM

ImmunityBio Inc. Revenue Breakdown

Quarter	Sep 30, 2024
Product and Service, Other Revenue	152.00K
Product and Service, Other Revenue Growth	n/a
Product Revenue	5.95M
Product Revenue Growth	n/a

Revenue by Geography

Quarter	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Europe Revenue	591.00K	198.00K	561.00K	n/a	n/a	21.00K
Europe Revenue Growth	+198.48%	-64.71%	n/a	n/a	-100.00%	n/a
United States Revenue	31.00K	42.00K	373.00K	45.00K	44.00K	n/a
United States Revenue Growth	-26.19%	-88.74%	+728.89%	+2.27%	n/a	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Selling, General, and Administrative Revenue	35.92M	49.25M	37.83M	29.05M	31.82M	32.02M	32.68M	26.21M	19.31M	16.57M	40.61M	27.91M	29.63M	32.45M	45.27M	23.88M	19.60M	18.35M	9.49M	8.53M	4.03M	4.18M	5.74M	5.25M	9.58M	13.59M	14.30M	13.38M	13.38M	14.13M	16.23M	15.71M	24.42M	28.59M	26.65M	74.83M	38.85M	82.43M
Selling, General, and Administrative Revenue Growth	-27.08%	+30.19%	+30.24%	-8.71%	-0.63%	-2.01%	+24.65%	+35.76%	+16.50%	-59.18%	+45.49%	-5.79%	-8.69%	-28.34%	+89.58%	+21.87%	+6.81%	+93.27%	+11.34%	+111.83%	-3.75%	-27.17%	+9.45%	-45.24%	-29.53%	-4.92%	+6.82%	+0.03%	-5.29%	-12.94%	+3.27%	-35.66%	-14.57%	+7.27%	-64.39%	+92.60%	-52.86%	n/a
Research and Development Revenue	50.44M	51.13M	52.85M	51.03M	48.40M	53.17M	79.26M	58.08M	71.61M	63.08M	55.38M	51.75M	49.28M	53.80M	41.13M	43.36M	35.77M	33.01M	27.37M	13.19M	12.05M	13.13M	12.60M	12.48M	14.56M	14.69M	13.99M	12.02M	11.07M	9.71M	9.25M	9.45M	8.36M	6.39M	4.94M	5.11M	3.95M	1.75M
Research and Development Revenue Growth	-1.34%	-3.26%	+3.56%	+5.43%	-8.96%	-32.92%	+36.48%	-18.90%	+13.52%	+13.91%	+7.00%	+5.02%	-8.41%	+30.81%	-5.14%	+21.20%	+8.38%	+20.57%	+107.49%	+9.47%	-8.22%	+4.23%	+0.95%	-14.28%	-0.88%	+4.98%	+16.39%	+8.60%	+14.04%	+4.95%	-2.09%	+12.92%	+30.91%	+29.23%	-3.17%	+29.27%	+126.36%	n/a